PeakData, founded in 2017 and headquartered in Switzerland, is pioneering the use of healthcare professional (HCP) data analytics in the pharmaceutical industry. Its platform stands out by offering agile targeting and segmentation capabilities that enable pharmaceutical companies to gain deeper insights into their customer base.
Used by more than half of the top 20 pharmaceutical companies, PeakData is making substantial inroads into the industry by helping these companies navigate the complexities of HCP data scattered across the web. Its presence is established globally, with a workforce of over 50, distributed across offices in the USA, Germany, UK, Poland, Netherlands, and Switzerland.
The company received a significant $12.15M Series A investment on 01 August 2022, securing backing from notable investors such as Octopus Ventures, Heal Capital, and Albion VC. This infusion of capital underscores confidence in their strategic direction and potential for growth.